董事会薪酬与考核委员会 关于 2025 年限制性股票与股票期权激励计划相关事项 的核查意见 海南双成药业股份有限公司 海南双成药业股份有限公司（以下简称"公司"）董事会薪酬与考核委员会 （以下简称"薪酬与考核委员会" ）根据《中华人民共和国公司法》 （以下简称《公 司法》） 、《中华人民共和国证券法》（以下简称《证券法》）、《上市公司股权激励 管理办法》 （以下简称《管理办法》）等有关法律、法规、规范性文件和《公司章 程》的有关规定，对公司《2025 年限制性股票与股票期权激励计划（草案）》 （以 下简称《激励计划（草案）》）及其相关事项进行了核查，发表核查意见如下： 一、关于公司《2025 年限制性股票与股票期权激励计划（草案）》及其摘要 的核查意见 情形，包括： （4）法律法规规定不得实行股权激励的； （5）中国证监会认定的其他情形。 》的制定、审议流程和内容符合《公司法》《证 券法》《管理办法》等有关法律、法规及规范性文件的规定：对各激励对象限制 性股票和股票期权的授予/行权安排及解除限售安排（包括授予/行权额度、授予 /行权日期、授予/行权价格、解除限售/行权条件等事项）未违反有关法律、法 规的规定， ...

网络投票时间：2025 年 9 月 19 日 证券代码：002693 证券简称：*ST双成 公告编号：2025-059 海南双成药业股份有限公司 关于召开2025年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 海南双成药业股份有限公司（以下简称"公司"）第五届董事会第二十一次 会议于 2025 年 9 月 1 日召开，会议定于 2025 年 9 月 19 日（星期五）召开 2025 年第二次临时股东会，现将本次股东会的有关事项通知如下： 一、召开会议的基本情况 后，决定召开股东会，本次股东会的召集程序符合法律、法规、规范性文件和《公 司章程》的规定。 （1）通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 19 日 9:15-9:25，9:30-11:30 和 13:00-15:00； （2）通过深圳证券交易所互联网投票系统投票的时间为 2025 年 9 月 19 日 公司股东应选择现场投票、网络投票中的一种方式，如果同一表决权出现重复投 票表决的，以第一次投票表决结果为准。 （1）截至 2025 年 9 月 ...

北京市中伦律师事务所 关于海南双成药业股份有限公司 法律意见书 二〇二五年九月 法律意见书 目 录 北京市中伦律师事务所 关于海南双成药业股份有限公司 法律意见书 致：海南双成药业股份有限公司 根据海南双成药业股份有限公司（以下简称"双成药业"或"公司"或"上 市公司"）与北京市中伦律师事务所（以下简称"本所"）签订的《法律顾问聘用 合同》的约定及受本所指派，本所律师作为公司 2025 年限制性股票与股票期权 激励计划（以下简称"激励计划"或"本激励计划"）相关事宜的专项法律顾问， 出具本法律意见书。 为出具本法律意见书，本所律师审阅了《海南双成药业股份有限公司 2025 年限制性股票与股票期权激励计划（草案）》 （以下简称《激励计划（草案）》）及 其摘要、 《海南双成药业股份有限公司 2025 年限制性股票与股票期权激励计划实 施考核管理办法》（以下简称《考核管理办法》）、《海南双成药业股份有限公司 员会会议文件、董事会会议文件以及本所律师认为需要审查的其他文件，并通过 查询政府部门公开信息对相关的事实和资料进行了核查和验证。 为出具本法律意见书，本所律师根据有关法律、法规、规范性文件的规定和 本所业务规则 ...

关于欧菲光集团股份有限公司 事项的法律意见书 中国 深圳 福田区 益田路 6001 号太平金融大厦 11、12 楼 邮政编码：518038 电话(Tel.)：(0755) 8826 5288 传真(Fax.)：(0755) 8826 5537 网址（Website）：www.sundiallawfirm.com 法律意见书 广东信达律师事务所 关于欧菲光集团股份有限公司 调整事项的法律意见书 信达励字（2025）第104号 致：欧菲光集团股份有限公司 广东信达律师事务所（以下简称"信达"）接受欧菲光集团股份有限公司（以 下简称"欧菲光"或"公司"）的委托，担任公司本次实行 2024 年第一期限制 性股票与股票期权激励计划（以下简称"本股权激励计划""本计划""本激励 计划"）的专项法律顾问。信达根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司股权激励管理办法》（以下简称"《管理办法》"）等有关法律、法规和规 范性文件以及《欧菲光集团股份有限公司章程》（以下简称"《公司章程》"）、 《欧菲光集团股份有限公司 2024 年第一期限制性股票与 ...

证券代码：002456 证券简称：欧菲光 公告编号：2025-067 欧菲光集团股份有限公司 关于修订 2023 年第一期股票期权激励计划（草 案） 、2024 年第一期限制性股票与股票期权激励计划 （草案）及相关文件的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 欧菲光集团股份有限公司（以下简称"公司"）于 2023 年 1 月 17 日分别召 开第五届董事会第十二次（临时）会议和第五届监事会第九次（临时）会议，审 议通过了《关于公司<2023 年第一期股票期权激励计划（草案）>及其摘要的议 案》 《关于公司<2023 年第一期股票期权激励计划实施考核管理办法>的议案》等 议案。公司于 2024 年 3 月 4 日分别召开第五届董事会第二十六次（临时）会议 和第五届监事会第二十一次（临时）会议，审议通过了《关于公司<2024 年第一 期限制性股票与股票期权激励计划（草案）>及其摘要的议案》 《关于公司<2024 年第一期限制性股票与股票期权激励计划实施考核管理办法>的议案》等议案。 具体内容详见公司分别于 2023 年 1 月 19 日、2024 年 ...

Core Viewpoint - The legal opinion letter from Junzejun Law Firm outlines the adjustments to the grant price and exercise price of stock options and the cancellation of certain restricted stocks and stock options for Shenzhen Fabon Information Technology Co., Ltd. as part of its 2023 incentive plan [1][2][12]. Summary by Sections Approval and Authorization of Adjustments and Cancellations - The company has completed necessary procedures for the adjustments and cancellations, including approvals from the board of directors and the supervisory board on multiple dates in 2023 and 2024 [5][6][7][8][9][10][11][12][15]. Details of the Adjustments - The adjustments were made in response to a cash dividend distribution approved by the shareholders, where the company will distribute 0.65 RMB per 10 shares, leading to a reduction in the grant and exercise prices [12][13]. - The adjusted grant price for restricted stocks is approximately 7.28 RMB per share, and the adjusted exercise price for stock options is approximately 14.73 RMB per share [13][14]. Cancellations of Restricted Stocks and Stock Options - The cancellation of restricted stocks and stock options is due to the departure of one incentive object, resulting in the cancellation of 8,478 shares of restricted stock and 8,478 stock options [14][15]. - The company has followed the required procedures for these cancellations, which do not require further shareholder approval [15]. Information Disclosure - The company has fulfilled its information disclosure obligations regarding the adjustments and cancellations, and will continue to disclose relevant information as required by laws and regulations [15][16].

Core Viewpoint - The company has announced adjustments to the grant price and exercise price of its 2023 restricted stock and stock option incentive plan, following necessary approvals and procedures [1][4][7]. Summary by Sections Approval Procedures - The incentive plan underwent several approval steps, including reviews by the compensation and assessment committee, board of directors, and supervisory board, all of which were completed by May 31, 2023 [2][3]. - The company held a temporary shareholders' meeting on June 19, 2023, where the incentive plan was approved [3]. Adjustment Details - The adjustment of the grant price and exercise price was necessitated by the completion of the 2024 annual equity distribution on May 30, 2025, which involved a cash dividend of 0.65 RMB per 10 shares [5][6]. - The adjusted grant price for restricted stock is approximately 7.28 RMB per share, and the adjusted exercise price for stock options is approximately 14.73 RMB per share [6]. Impact on the Company - The adjustments comply with relevant regulations and will not materially affect the company's financial status or operational results [6][7]. Supervisory Board Opinion - The supervisory board agrees that the adjustments are in line with legal and regulatory requirements and do not harm the interests of the company or its shareholders [7]. Legal Opinion - The legal firm has confirmed that the adjustments and cancellations have received necessary approvals and comply with applicable laws and regulations [7][8].

Core Viewpoint - The company has announced adjustments to the grant prices and exercise prices of its 2022 and 2024 stock incentive plans, following the completion of its equity distribution plan for 2024 [1][14]. Group 1: 2022 Stock Incentive Plan Adjustments - The grant price for the second category of restricted stock has been adjusted from 19.60 CNY/share to 19.53 CNY/share, and the exercise price for stock options has been adjusted from 39.19 CNY/option to 39.12 CNY/option [5][12]. - The number of recipients for the second category of restricted stock has been reduced from 2,254 to 2,248, with the total number of shares granted adjusted from 8.24 million to 8.234 million [3][4]. - The number of stock options granted has been adjusted from 16.69 million to 16.67 million, with the number of recipients reduced from 1,059 to 1,049 [3][4]. Group 2: 2024 Stock Incentive Plan Details - The 2024 stock incentive plan proposes to grant 14.601258 million shares of restricted stock to 730 recipients at a price of 6.90 CNY/share [11][12]. - Following adjustments, the grant price for the 2024 restricted stock has been revised from 6.90 CNY/share to 6.78 CNY/share due to the completion of the equity distribution plan [12][14]. - The number of recipients for the 2024 plan has been adjusted from 730 to 726, with the total number of shares granted adjusted from 14.601258 million to 14.593258 million [12][14]. Group 3: Compliance and Approval - The adjustments to the incentive plans have been approved by the board and comply with relevant regulations, ensuring no harm to shareholder interests [14][15]. - The company has completed necessary procedures for the adjustments, including independent opinions from the board and the supervisory committee [14][15].

Meeting Overview - The seventh session of the Supervisory Board of Shanghai Baolong Automotive Technology Co., Ltd. was held on May 23, 2025, via email notification to all supervisors, complying with relevant laws and regulations [1] Agenda Items Adjustment of Stock Option Exercise Prices - The Supervisory Board approved the adjustment of the exercise price for reserved stock options under the 2021 Restricted Stock and Stock Option Incentive Plan from 52.89 CNY/share to 52.38 CNY/share, aligning with the company's 2024 annual cash dividend and relevant regulations [1][2] - The Supervisory Board also approved the adjustment of the exercise price for the 2023 Incentive Plan from 44.26 CNY/share to a new price, ensuring compliance with the regulations and no harm to shareholder interests [2] Repurchase and Cancellation of Stock Options - The Supervisory Board approved the repurchase and cancellation of certain restricted stocks and stock options under the 2023 Incentive Plan, confirming that the actions are in accordance with relevant laws and will not affect the implementation of the incentive plan or harm the interests of the company and its shareholders [3]

Core Viewpoint - The legal opinion letter from Shanghai Dongfang Huayin Law Firm addresses the adjustments to the 2024 restricted stock and stock option incentive plan of Shanghai Jinghua Adhesive New Materials Co., Ltd, including the repurchase price of restricted stocks and the cancellation of certain stock options and restricted stocks [1][2][4]. Group 1: Approval and Authorization - The approval and authorization for the 2024 restricted stock and stock option incentive plan were conducted in accordance with relevant laws and regulations, with specific proposals reviewed and approved by the company's board and supervisory committee [5][7]. - The board's authorization allows for the adjustment of the incentive plan, including the cancellation of stock options and repurchase of restricted stocks for two individuals who have left the company [8][9]. Group 2: Repurchase Price Adjustment - The repurchase price for restricted stocks has been adjusted from 4.24 CNY per share to 4.15 CNY per share, following the company's profit distribution plan [9][11]. - The adjustment is based on the company's decision to distribute a cash dividend of 0.09 CNY per share, which necessitates a recalibration of the repurchase price [10][11]. Group 3: Cancellation and Repurchase Details - The company plans to cancel a total of 50,000 stock options and repurchase 64,400 restricted stocks from the two individuals who no longer qualify as incentive targets due to personal reasons [12][15]. - The total payment for the repurchase of restricted stocks will amount to 267,260 CNY, which will be funded from the company's own resources [12][14]. Group 4: Compliance and Future Steps - The adjustments and cancellations have been deemed compliant with the relevant regulations, and the company is required to fulfill information disclosure obligations and complete the necessary legal procedures for share cancellation and reduction [15][16]. - The legal opinion confirms that all necessary approvals and authorizations have been obtained for the adjustments and cancellations, ensuring alignment with the company's incentive plan and regulatory requirements [15].